Literature DB >> 28656629

P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.

Sara Laudato1,2, Nitin Patil1,2, Mohammed L Abba1,2, Joerg H Leupold1,2, Axel Benner3, Timo Gaiser4, Alexander Marx4, Heike Allgayer1,2.   

Abstract

The tumor suppressor P53 is a critical regulator of normal cellular homeostasis whose function is either distorted or lost in several cancer types including colorectal cancer (CRC). A small group of microRNAs have come to be recognized as essential mediators of P53 function. In a genome-wide systematic approach, we explored miRNAs that are substantially altered by P53 loss and found miR-30e to be the most significantly deregulated miRNA in P53-knockout human CRC cells. We identified miR-30e-5p to be a novel direct transcriptional target of P53 with gain and loss of function experiments revealing miR-30e-5p to be a significant regulator of tumor cell migration, invasion and in vivo metastasis mediated in part by integrins alpha-6 and beta-1 as novel targets. MiR-30e-5p also significantly reduced tumor cell proliferation by causing G1/S cell cycle arrest, which was achieved by inducing P21 and P27 expression. Finally, we found miR-30e-5p to be lost in resected CRC tumors as compared to normal colon tissues. Taken together, miR-30e-5p is a novel effector of P53-induced suppression of migration, invasion and metastasis.
© 2017 UICC.

Entities:  

Keywords:  P53; cancer; integrins; metastasis; miR-30e; microRNAs

Mesh:

Substances:

Year:  2017        PMID: 28656629     DOI: 10.1002/ijc.30854

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  MiR-302a-5p suppresses cell proliferation and invasion in non-small cell lung carcinoma by targeting ITGA6.

Authors:  Wei Chen; Xibing Zhuang; Ruixue Qi; Tiankui Qiao
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 2.  microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Ulrich Brinkmann; Simon Auslaender
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

3.  2-Amino-4-(1-piperidine) pyridine exhibits inhibitory effect on colon cancer through suppression of FOXA2 expression.

Authors:  Jieshu Wang; Bo Li; Kun Zhao; Xinyou Su
Journal:  3 Biotech       Date:  2019-10-04       Impact factor: 2.406

4.  LIN28B increases neural crest cell migration and leads to transformation of trunk sympathoadrenal precursors.

Authors:  Diana Corallo; Michael Donadon; Marcella Pantile; Viktoryia Sidarovich; Simona Cocchi; Michela Ori; Miriam De Sarlo; Simona Candiani; Chiara Frasson; Martin Distel; Alessandro Quattrone; Carlo Zanon; Giuseppe Basso; Gian Paolo Tonini; Sanja Aveic
Journal:  Cell Death Differ       Date:  2019-10-10       Impact factor: 15.828

5.  Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond-Blackfan anemia.

Authors:  Mark C Wilkes; Vanessa Scanlon; Aya Shibuya; Alma-Martina Cepika; Ascia Eskin; Zugen Chen; Anupama Narla; Bert Glader; Maria Grazia Roncarolo; Stanley F Nelson; Kathleen M Sakamoto
Journal:  Exp Hematol       Date:  2022-04-20       Impact factor: 3.249

6.  Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Naoko Kikkawa; Toyoyuki Hanazawa; Yasutaka Yamada; Atsushi Okato; Takayuki Arai; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Oncotarget       Date:  2017-12-11

7.  The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.

Authors:  Tingting Zhu; Ruifang Chen; Jieyu Wang; Huiran Yue; Xin Lu; Jun Li
Journal:  Cancer Cell Int       Date:  2020-06-18       Impact factor: 5.722

8.  Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p.

Authors:  Tao Cheng; Shuai Ding; Shanshan Liu; Xiaojing Li; Xiaojun Tang; Lingyun Sun
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

9.  Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation.

Authors:  Zhigao Niu; Wenping Zhang; Jialun Shi; Xiangdong Li; Hanlei Wu
Journal:  J Cardiothorac Surg       Date:  2021-07-07       Impact factor: 1.637

10.  FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.

Authors:  Baolei Wang; Guangwei Liu; Lei Ding; Jun Zhao; Yun Lu
Journal:  Exp Ther Med       Date:  2018-05-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.